ADC Therapeutics SA (ADCT) Operating income 2022–2025
ADC Therapeutics SA (ADCT) annual operating income history from SEC filings — each fiscal year as reported.
-$121.5MFY2025 · since FY2022: -$123.3M → -$121.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$121.5M | +7.0% |
| FY2024 | -$130.7M | +21.3% |
| FY2023 | -$166.0M | -34.6% |
| FY2022 | -$123.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Net marginADCT Gross profitADCT Gross marginADCT Operating marginADCT Operating cash flowADCT Free cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →